Also note: Mentored Clinical Scientist Research Career Development Award in Muscular Dystrophy Research (K08): PA-11-077
Details at: http://grants.nih.gov/grants/guide/pa-files/PA-11-077.html
Also note: NIH Pathway to Independence Award in Muscular Dystrophy Research (K99/R00) (PA-11-078)
Details at: http://grants.nih.gov/grants/guide/pa-files/PA-11-078.html
Components of Participating Organizations
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): Multiple dates, see announcement
The overall goal of NIH-supported career development programs is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation's biomedical, behavioral, and clinical research needs.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are interested in supporting additional career development and mentoring opportunities in muscular dystrophy research. NIAMS and NICHD will provide career development awards to promising clinically trained applicants with the potential to become productive, independent investigators in basic, translational, and clinical research on the muscular dystrophies. This funding opportunity Announcement (FOA) is issued in recognition of the urgent need for highly skilled, interactive investigators who are able to integrate various disciplines and levels of expertise to successfully address the increasing challenges in the current research environment of the muscular dystrophies. This FOA calls for applications for mentored career development awards for clinical scientist engaged in patient-oriented research (POR). It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies.
This FOA will utilize the K23 grant mechanism and runs in …